Friday, January 13, 2017

Indian pepper holds key for new cancer-fighting drug

The Indian long pepper, widely popular for spicing up food, may soon be used as a potential cancer treatment drug, according to a new study.
The Indian long pepper contains a chemical that could stop your body from producing an enzyme that is commonly found in tumors in large numbers, according to the study in Journal of Biological Chemistry.

UT Southwestern Medical Center scientists have uncovered the chemical process behind anti-cancer properties of a spicy Indian pepper plant called the long pepper, whose suspected medicinal properties date back thousands of years.

The secret lies in a chemical called Piperlongumine (PL), which has shown activity against many cancers including prostate, breast, lung, colon, lymphoma, leukemia, primary brain tumors and gastric cancer.

Using x-ray crystallography, researchers were able to create molecular structures that show how the chemical is transformed after being ingested. PL converts to hPL, an active drug that silences a gene called GSTP1. The GSTP1 gene produces a detoxification enzyme that is often overly abundant in tumors, the study said.

"We are hopeful that our structure will enable additional drug development efforts to improve the potency of PL for use in a wide range of cancer therapies," said Dr Kenneth Westover, Assistant Professor of Biochemistry and Radiation Oncology.

"This research is a spectacular demonstration of the power of x-ray crystallography." The long pepper, a plant native to India, is found in southern India and southeast Asia. Although rare in European fare, it is commonly found in Indian stores and used as a spice or seasoning in stews and other dishes. 


 It dates back thousands of years in the Indian subcontinent tied to Ayurveda, one of the world's oldest medical systems.

"This study illustrates the importance of examining and re-examining our theories. In this case we learned something fundamentally new about a 3,000-year-old medical claim using modern science," said Westover. 


 X-ray crystallography allows scientists to determine molecular structures that reveal how molecules interact with targets - in this case how PL interacts with GSTP1.

This work is supported by the V Foundation for Cancer Research, founded by ESPN and legendary basketball coach Jim Valvano, The Welch Foundation, and the Cancer Prevention and Research Institute of Texas. 


 this is only for your information, kindly take the advice of your doctor for medicines, exercises and so on.
https://gscrochetdesigns.blogspot.com. one can see my crochet creations

https://gseasyrecipes.blogspot.com. feel free to view for easy, simple and healthy recipes  
https://kneereplacement-stickclub.blogspot.com. for info on knee replacement 

Labels: , , , , , , , , , , , , , ,

Friday, March 18, 2016

Psychiatric symptoms could be sign of brain tumour

THIS IS ONLY FOR INFORMATION, ALWAYS CONSULT YOUR PHYSICIAN BEFORE HAVING ANY PARTICULAR FOOD/ MEDICATION/EXERCISE/OTHER REMEDIES.




FOR INFO ABOUT KNEE REPLACEMENT, YOU CAN VIEW MY BLOG
HTTP://KNEE REPLACEMENT-STICK CLUB.BLOGSPOT.COM/

FOR CROCHET DESIGNS- http://My Crochet Creations.blogspot.com/


 The 54-year-old woman had been depressed for six months, but treatment with the antidepressant fluoxetine and the anti-anxiety medication bromazepam was discontinued after five months because these were not found to be effective, says an article published in BMJ Case Reports.

The patient's symptoms included apathy, difficulties with making decisions and initiating action, a lack of energy, sleep disorders, and concentration and attention problems.

She had suicidal thoughts, admitted self-accusation due to ineffectiveness in her job, and lost interest in her usual past times.

She did not have a history of personal or familial mental illness, but experienced several stressful events.


 A neurological examination was normal. However, a brain CT scan and MRI revealed meningiomatosis with a giant meningioma -- the most common primary benign brain tumour -- in her left frontal lobe.

This is an area known to have an important role in the development of depression for patients with tumours in the brain.

The patient underwent emergency surgery, and made a recovery. The depressive symptoms disappeared within one month.

The doctors in the article say that certain patients should have a brain scan to identify or exclude the possibility of a tumour, but note that "it seems unrealistic to prescribe brain imaging in every patient with a depressive syndrome" because this mental disorder is common while brain tumours are "remarkably rare" in patients with depression.

They recommend that it should be performed if the patient presents a late onset of depressive syndrome after 50 years of age, if a diagnosis of treatment-resistant depression is made or if the patient is apathetic.

Labels: , , , , , , , , ,